Fortuna Fix is a next-generation regenerative medicine company focused on neuronal repair and regeneration.
Fortuna Fix's goal is to establish regenerative medicine as a new paradigm of healthcare, bringing real solutions to conditions that cannot be cured by current therapeutic modalities.
Fortuna Fix was founded in 2015. The company is based in Laval, Quebec, Canada and has it's headquarter in London, London, UK.
Fortuna Fix operates through direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx) for the treatment of neurodegenerative diseases and neurotrauma.